LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 513 | 1100 | 10401 | 0.1058 | 0.0593 |
MCF 10A | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 513 | 1101 | 10401 | 0.1059 | 0.0595 |
MCF 10A | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 513 | 1104 | 10401 | 0.1062 | 0.0598 |
MCF 10A | Torin1 | 1.11 | uM | LJP6 | 72 | hr | 513 | 1111 | 10401 | 0.1069 | 0.0605 |
MCF 10A | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 513 | 1114 | 10401 | 0.1071 | 0.0608 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 1120 | 10401 | 0.1077 | 0.0614 |
MCF 10A | Y39983 | 10.0 | uM | LJP6 | 72 | hr | 513 | 1133 | 10401 | 0.1090 | 0.0627 |
MCF 10A | NVP-AEW541 | 10.0 | uM | LJP5 | 72 | hr | 513 | 1146 | 10401 | 0.1102 | 0.0640 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 1147 | 10401 | 0.1103 | 0.0641 |
MCF 10A | WH-4-025 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1148 | 10401 | 0.1104 | 0.0642 |
MCF 10A | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 1150 | 10401 | 0.1106 | 0.0644 |
MCF 10A | Dactolisib | 10.0 | uM | LJP5 | 72 | hr | 513 | 1157 | 10401 | 0.1112 | 0.0651 |
MCF 10A | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1165 | 10401 | 0.1120 | 0.0659 |
MCF 10A | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 513 | 1183 | 10401 | 0.1138 | 0.0678 |
MDA-MB-231 | Celastrol | 10.0 | uM | LJP6 | 72 | hr | 868 | 402 | 3486 | 0.1155 | -0.1778 |
MCF 10A | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 513 | 1211 | 10401 | 0.1165 | 0.0706 |
MCF 10A | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 513 | 1215 | 10401 | 0.1168 | 0.0710 |
BT-20 | A443654 | 10.0 | uM | LJP6 | 72 | hr | 1657 | 652 | 5505 | 0.1185 | -0.2613 |
MCF 10A | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 513 | 1235 | 10401 | 0.1188 | 0.0731 |
MCF 10A | PHA-793887 | 0.04 | uM | LJP6 | 72 | hr | 513 | 1245 | 10401 | 0.1198 | 0.0741 |
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 513 | 1268 | 10401 | 0.1219 | 0.0763 |
MCF 10A | Seliciclib | 10.0 | uM | LJP5 | 72 | hr | 513 | 1269 | 10401 | 0.1220 | 0.0764 |
BT-20 | CGP60474 | 10.0 | uM | LJP6 | 72 | hr | 1657 | 673 | 5505 | 0.1224 | -0.2557 |
MCF7 | Alvocidib | 10.0 | uM | LJP6 | 72 | hr | 1235 | 512 | 4156 | 0.1233 | -0.2476 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 513 | 1287 | 10401 | 0.1238 | 0.0783 |